12967_2018_1427_MOESM4_ESM.tif (9.44 MB)

MOESM4 of Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

figure

posted on 2018-03-09, 05:00 authored by Mitchell Lie, Janine Giessen, Gwenny Fuhler, Alison Lima, Maikel Peppelenbosch, Cokkie Ent, C. Woude

Additional file 4: Figure S3. GRP78 staining specificity. A patient with no GRP78 expression (left panel) and a patient showing clusters of GRP78 positivity alongside negative tissue (right panel) are shown.

History

Usage metrics

Keywords

Crohnâs disease Ulcerative colitis Naltrexone Endoplasmic reticulum stress Wound healing

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM